Sanz-Cuesta T, Escortell-Mayor E, Cura-Gonzalez I et al (2020) Oral versus intramuscular administration of vitamin B12 for vitamin B12 deficiency in primary care: a pragmatic, randomized, non-inferiority clinical trial (OB12)
hives, difficulty breathing)
A deficiency can lead to fatigue, weakness, and neurological issues like numbness or tingling
The substance itself is banned, regardless of whether its in an injectable form like our [BPC 157 Peptide]( or oral forms like [BPC 157 Capsules]( Any presence of the compound in an athletes system constitutes a violation
[1] [4] The medication is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg once weekly for 4 weeks, then increased by 2.5 mg every 4 weeks as needed and tolerated up to 15 mg
Injectable BPC-157 used in pre-clinical animal research and in off-label clinical settings typically involves higher doses and subcutaneous or intraperitoneal administration